Zonagen (zona) - good buy? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Dauntless who wrote (2385)	2/18/1998 1:23:00 PM
From: Linda Kaplan	Read Replies (1) of 7041

Dauntless, First Call has a research report from Wessels, Arnold & Henderson, LLC. This report says that Zonagen has been experiencing a 50% dropout rate from clinical trials on Vasomax, that Viagra appears to be set for approval end Feb or early March, that in the clinical trials of Vasomax, men taking the highest dosage of Vasomax are suffering from severe vomiting and nausea and that the men taking the lowest and middle dosages are not getting satisfactory responses. And, Zonagen is considering a new series of clinical studies. Linda

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next